ProfileGDS4718 / 212365_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 88% 58% 85% 86% 89% 87% 84% 82% 87% 90% 81% 92% 86% 87% 84% 83% 90% 86% 90% 87% 82% 87% 83% 86% 86% 83% 84% 85% 88% 86% 89% 86% 88% 82% 88% 87% 88% 81% 64% 86% 86% 86% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6829186
GSM549102patient 115, normal, homogenized [OPG study]8.9006688
GSM549104patient 119, normal, homogenized [OPG study]5.9814958
GSM549108patient 138, normal, homogenized [OPG study]8.3600785
GSM549119patient 077, normal, homogenized [OPG study]8.539986
GSM549133patient 032, cancer, homogenized [OPG study]9.1292689
GSM549139patient 042, cancer, homogenized [OPG study]8.7435987
GSM549099patient 107, normal, homogenized [OPG study]8.2514784
GSM549109patient 139, normal, homogenized [OPG study]7.9795982
GSM549110patient 046, normal, homogenized [OPG study]8.689387
GSM549114patient 063, normal, homogenized [OPG study]9.3073890
GSM549122patient 082, normal, homogenized [OPG study]7.9931181
GSM549134patient 033, cancer, homogenized [OPG study]9.5813592
GSM549136patient 036, cancer, homogenized [OPG study]8.6421686
GSM549140patient 044, cancer, homogenized [OPG study]8.7440787
GSM549111patient 047, normal, homogenized [OPG study]8.4150184
GSM549113patient 057, normal, homogenized [OPG study]8.3123683
GSM549132patient 031, cancer, homogenized [OPG study]9.1114490
GSM549137patient 038, cancer, homogenized [OPG study]8.6204286
GSM549142patient 047, cancer, homogenized [OPG study]8.7529390
GSM549100patient 110, normal, homogenized [OPG study]8.7559487
GSM549107patient 135, normal, homogenized [OPG study]8.1734482
GSM549115patient 068, normal, homogenized [OPG study]8.9262787
GSM549116patient 072, normal, homogenized [OPG study]8.2182983
GSM549120patient 078, normal, homogenized [OPG study]8.620986
GSM549131patient 030, cancer, homogenized [OPG study]8.6920486
GSM549118patient 074, normal, homogenized [OPG study]8.2397183
GSM549129patient 027, cancer, homogenized [OPG study]8.3001884
GSM549123patient 088, normal, homogenized [OPG study]8.4427885
GSM549124patient 006, cancer, homogenized [OPG study]8.7711588
GSM549126patient 015, cancer, homogenized [OPG study]8.6227186
GSM549128patient 025, cancer, homogenized [OPG study]9.0271389
GSM549103patient 117, normal, homogenized [OPG study]8.4334386
GSM549117patient 073, normal, homogenized [OPG study]9.0726788
GSM549138patient 041, cancer, homogenized [OPG study]8.1188282
GSM549141patient 045, cancer, homogenized [OPG study]9.0312388
GSM549130patient 028, cancer, homogenized [OPG study]8.6312887
GSM549101patient 111, normal, homogenized [OPG study]8.7777988
GSM549105patient 128, normal, homogenized [OPG study]7.9018781
GSM549106patient 134, normal, homogenized [OPG study]6.3913164
GSM549112patient 048, normal, homogenized [OPG study]8.6533186
GSM549125patient 011, cancer, homogenized [OPG study]8.4771486
GSM549127patient 024, cancer, homogenized [OPG study]8.6289186
GSM549135patient 035, cancer, homogenized [OPG study]9.2379290